Mengxue Pei - Search Results

Year	Number of Results
2001	1
2002	1
2003	1
2004	2
2005	1
2006	1
2007	1
2008	2
2009	4
2010	1
2011	1
2012	1
2013	2
2018	1
2019	1
2021	2
2022	3
2023	1
2024	1

1

Apoptosis in the treatment of cancer: a promise kept?

Meng XW, Lee SH, Kaufmann SH. Meng XW, et al. Curr Opin Cell Biol. 2006 Dec;18(6):668-76. doi: 10.1016/j.ceb.2006.10.008. Epub 2006 Oct 16. Curr Opin Cell Biol. 2006. PMID: 17049222 Review.

2

Formal synthesis of (±)-morphine.

Li J, Liu GL, Zhao XH, Du JY, Qu H, Chu WD, Ding M, Jin CY, Wei MX, Fan CA. Li J, et al. Among authors: wei mx. Chem Asian J. 2013 Jun;8(6):1105-9. doi: 10.1002/asia.201300139. Epub 2013 Mar 18. Chem Asian J. 2013. PMID: 23509056

3

Synthesis and biological evaluation of novel artemisone-piperazine-tetronamide hybrids.

Wei MX, Yu JY, Liu XX, Li XQ, Yang JH, Zhang MW, Yang PW, Zhang SS, He Y. Wei MX, et al. RSC Adv. 2021 May 21;11(30):18333-18341. doi: 10.1039/d1ra00750e. eCollection 2021 May 19. RSC Adv. 2021. PMID: 35480921 Free PMC article.

4

Correction: High cell surface death receptor expression determines type I versus type II signaling.

Meng XW, Peterson KL, Dai H, Schneider P, Lee SH, Zhang JS, Koenig A, Bronk S, Billadeau DD, Gores GJ, Kaufmann SH. Meng XW, et al. J Biol Chem. 2022 May;298(5):101980. doi: 10.1016/j.jbc.2022.101980. Epub 2022 Apr 28. J Biol Chem. 2022. PMID: 35490622 Free PMC article. No abstract available.

5

Design, Synthesis, and Biological Evaluation of Artemisinin-Piperazine-Phosphoramide Mustard Hybrids as Potential Anticancer Agents.

Wei MX, Zhang SS, Sun X, Ji Y, Yang PW, Li XQ. Wei MX, et al. ChemMedChem. 2022 Sep 5;17(17):e202200239. doi: 10.1002/cmdc.202200239. Epub 2022 Jul 13. ChemMedChem. 2022. PMID: 35771689

6

Synthesis and biological activities of artemisinin-piperazine-dithiocarbamate derivatives.

Yu JY, Li XQ, Wei MX. Yu JY, et al. Among authors: wei mx. Eur J Med Chem. 2019 May 1;169:21-28. doi: 10.1016/j.ejmech.2019.02.071. Epub 2019 Mar 2. Eur J Med Chem. 2019. PMID: 30852384

7

Design, synthesis and biological evaluation of rhein-piperazine-dithiocarbamate hybrids as potential anticancer agents.

Wei MX, Zhou YX, Lin M, Zhang J, Sun X. Wei MX, et al. Eur J Med Chem. 2022 Nov 5;241:114651. doi: 10.1016/j.ejmech.2022.114651. Epub 2022 Aug 5. Eur J Med Chem. 2022. PMID: 35963130

8

Design, synthesis and biological evaluation of matrine-dithiocarbamate hybrids as potential anticancer agents.

Zhang MW, He Y, Wei MX. Zhang MW, et al. Among authors: wei mx. Eur J Med Chem. 2023 Jun 5;254:115375. doi: 10.1016/j.ejmech.2023.115375. Epub 2023 Apr 11. Eur J Med Chem. 2023. PMID: 37084600

9

Synthesis of artemisinin-piperazine-furan ether hybrids and evaluation of in vitro cytotoxic activity.

Wei MX, Yu JY, Liu XX, Li XQ, Zhang MW, Yang PW, Yang JH. Wei MX, et al. Eur J Med Chem. 2021 Apr 5;215:113295. doi: 10.1016/j.ejmech.2021.113295. Epub 2021 Feb 16. Eur J Med Chem. 2021. PMID: 33636536

10

Anticancer therapy: boosting the bang of Bim.

Hendrickson AW, Meng XW, Kaufmann SH. Hendrickson AW, et al. Among authors: meng xw. J Clin Invest. 2008 Nov;118(11):3582-4. doi: 10.1172/JCI37553. Epub 2008 Oct 23. J Clin Invest. 2008. PMID: 18949061 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

25 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year